Celera Turns Q4 Profit as Revenues Falter | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Celera reported after the close of the market Wednesday that its fourth-quarter revenues declined 15 percent due to a drop in its lab services receipts.

The Alameda, Calif.-based molecular diagnostics firm brought in total revenues of $40 million for the three-month period ended Dec. 26, 2009, down from revenues of $47.3 million for the fourth quarter of 2008. The results edged analysts' consensus estimate of $39.6 million for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.